Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: UNIVERSITY OF MARYLAND BALTIMORE
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2025-08-27 to 2027-09-29
Current total value of award: $288274
Description: THE CARB (COMBATING ANTIMICROBIAL RESISTANCE BACTERIA) RESEARCH PROGRAM IDENTIFIES RESEARCH AREAS TO FUND WHERE REGULATORY SCIENCE CAN SUPPORT NEW ANTIBACTERIAL DRUG DEVELOPMENT IN GENERAL, BY CREATING NEW DRUG DEVELOPMENT TOOLS OR STANDARDS FOR U